Positive association of HLA-DRB1*15 with Dupuytren's disease in Caucasians

Tissue Antigens

Volumn 72, Issue 2, 2008, Pages 166-170

  Brown, J J ^a,b   Ollier, W ^b   Thomson, W ^b   Bayat, A ^a,b  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Caucasian ethnicity; Dupuytren contracture; Dupuytren's disease; HLA DRB1; Major histocompatibility complex; Polymerase chain reaction sequence specific oligonucleotide probe

Indexed keywords

HLA DR ANTIGEN;

ADULT; AGED; ALLELE; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DUPUYTREN CONTRACTURE; FEMALE; GENE FREQUENCY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DUPUYTREN'S CONTRACTURE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HLA-DR ANTIGENS; HUMANS; LINKAGE (GENETICS); MALE; MIDDLE AGED;

EID: 47549103109     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2008.01082.x     Document Type: Article

References (45)

1. Leclercq C. Results of surgical treatment. In : Tubiana R, Leclercq C, Hurst LC, Badalamente MA, Mackin EJ, eds. Dupuytren's Disease, 1st edn. London : Martin Dunitz, 2000, 239 50.
2. Burge P. Genetics of Dupuytren's disease. Hand Clin 1999 : 15 : 63 71.
3. Hueston JT. Dupuytren's contracture. In : Jupiter IJB ed. Flynn's Hand Surgery, 4th edn. Baltimore : Williams & Wilkins & Wilkins, 1991, 864 89.
4. Hunter JA, Ogdon C, Norris MG. Dupuytren's contracture I-Chemical pathology. Br J Plast Surg 1975 : 28 : 10 8.
5. Ling RS. The genetic factor in Dupuytren's disease. J Bone Joint Surg Br 1963 : 45 : 709 18.
6. Bayat A, Watson JS, Stanley JK et al. Genetic susceptibility in Dupuytren's disease. TGF-beta1 polymorphisms and Dupuytren's disease. J Bone Joint Surg Br 2002 : 84 : 211 5.
7. Bayat A, Alansar A, Hajeer AH et al. Genetic susceptibility in Dupuytren's disease: lack of association of a novel transforming growth factor beta(2) polymorphism in Dupuytren's disease. J Hand Surg [Br] 2002 : 27 : 47 9.
8. Bayat A, Stanley JK, Watson JS, Ferguson MW, Ollier WE. Genetic susceptibility to Dupuytren's disease: transforming growth factor beta receptor (TGFbetaR) gene polymorphisms and Dupuytren's disease. Br J Plast Surg 2003 : 56 : 328 33.
9. Bayat A, Watson JS, Stanley JK, Ferguson MW, Ollier WE. Genetic susceptibility to dupuytren disease: association of Zf9 transcription factor gene. Plast Reconstr Surg 2003 : 111 : 2133 9.
10. Neumuller J, Menzel J, Millesi H. Prevalence of HLA-DR3 and autoantibodies to connective tissue components in Dupuytren's contracture. Clin Immunol Immunopathol 1994 : 71 : 142 8.
11. Thomson W, Barrett JH, Donn R et al. Juvenile idiopathic arthritis classified by the ILAR criteria: hLA associations in UK patients. Rheumatology (Oxford) 2002 : 41 : 1183 9.
12. Bayat A, Walter J, Lambe H et al. Identification of a novel mitochondrial mutation in Dupuytren's disease using multiplex DHPLC. Plast Reconstr Surg 2005 : 115 : 134 41.
13. Gay S, Gay B. [Is Dupuytren's contracture an autoimmune disease?]. Zentralbl Chir 1972 : 97 : 728 33.
14. Menzel EJ, Piza H, Zielinski C, Endler AT, Steffen C, Millesi H. Collagen types and anticollagen-antibodies in Dupuytren's disease. Hand 1979 : 11 : 243 8.
15. Pereira RS, Black CM, Turner SM, Spencer JD. Antibodies to collagen types I-VI in Dupuytren's contracture. J Hand Surg [Br] 1986 : 11 : 58 60.
16. Spencer JD, Walsh KI. Histocompatibility antigen patterns in Dupuytren's contracture. J Hand Surg [Br] 1984 : 9 : 276 8.
17. Tait BD, Mackay IR. HLA phenotypes in Dupuytren's contracture. Tissue Antigens 1982 : 19 : 240 1.
18. Williams PL, Dann J, James DC, Timlin D. Histocompatibility antigens in subgroups of Dupuytren's contracture. Br J Rheumatol 1983 : 22 : 60 1.
19. Joung CI, Jun JB, Chung WT et al. Association between the HLA-DRB1 gene and clinical features of systemic sclerosis in Korea. Scand J Rheumatol 2006 : 35 : 39 43.
20. Szucs G, Szekanecz Z, Zilahi E et al. Systemic sclerosis-rheumatoid arthritis overlap syndrome: a unique combination of features suggests a distinct genetic, serological and clinical entity. Rheumatology (Oxford) 2007 : 46 : 989 93.
21. Hedfors E, Lindstrom F. HLA-B8/DR3 in sarcoidosis. Correlation to acute onset disease with arthritis. Tissue Antigens 1983 : 22 : 200 3.
22. Gardner J, Kennedy HG, Hamblin A, Jones E. HLA associations in sarcoidosis: a study of two ethnic groups. Thorax 1984 : 39 : 19 22.
23. Abe S, Yamaguchi E, Makimura S, Okazaki N, Kunikane H, Kawakami Y. Association of HLA-DR with sarcoidosis. Correlation with clinical course. Chest 1987 : 92 : 488 90.
24. Bogunia-Kubik K, Tomeczko J, Suchnicki K, Lange A. HLA-DRB1*03, DRB1*11 or DRB1*12 and their respective DRB3 specificities in clinical variants of sarcoidosis. Tissue Antigens 2001 : 57 : 87 90.
25. Foley PJ, McGrath DS, Puscinska E et al. Human leukocyte antigen-DRB1 position 11 residues are a common protective marker for sarcoidosis. Am J Respir Cell Mol Biol 2001 : 25 : 272 7.
26. Ishihara M, Ohno S, Ishida T et al. Molecular genetic studies of HLA class II alleles in sarcoidosis. Tissue Antigens 1994 : 43 : 238 41.
27. Nowack D, Goebel KM. Genetic aspects of sarcoidosis. Class II histocompatibility antigens and a family study. Arch Intern Med 1987 : 147 : 481 3.
28. Rutherford RM, Brutsche MH, Kearns M, Bourke M, Stevens F, Gilmartin JJ. HLA-DR2 predicts susceptibility and disease chronicity in Irish sarcoidosis patients. Sarcoidosis Vasc Diffuse Lung Dis 2004 : 21 : 191 8.
29. Rossman MD, Thompson B, Frederick M et al. HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. Am J Hum Genet 2003 : 73 : 720 35.
30. Sato H, Grutters JC, Pantelidis P et al. HLA-DQB1*0201: a marker for good prognosis in British and Dutch patients with sarcoidosis. Am J Respir Cell Mol Biol 2002 : 27 : 406 12.
31. Martorana D, Vaglio A, Greco P et al. Chronic periaortitis and HLA-DRB1*03: another clue to an autoimmune origin. Arthritis Rheum 2006 : 55 : 126 30.
32. Rasmussen TE, Hallett JW Jr., Metzger RL et al. Genetic risk factors in inflammatory abdominal aortic aneurysms: polymorphic residue 70 in the HLA-DR B1 gene as a key genetic element. J Vasc Surg 1997 : 25 : 356 64.
33. Montserrat V, Galocha B, Marcilla M, Vazquez M, Lopez de Castro JA. HLA-B*2704, an allotype associated with ankylosing spondylitis, is critically dependent on transporter associated with antigen processing and relatively independent of tapasin and immunoproteasome for maturation, surface expression, and T cell recognition: relationship to B*2705 and B*2706. J Immunol 2006 : 177 : 7015 23.
34. Hirose S, Jiang Y, Nishimura H, Shirai T. Significance of MHC class II haplotypes and IgG Fc receptors in SLE. Springer Semin Immunopathol 2006 : 28 : 163 74.
35. Annese V, Piepoli A, Latiano A et al. HLA-DRB1 alleles may influence disease phenotype in patients with inflammatory bowel disease: a critical reappraisal with review of the literature. Dis Colon Rectum 2005 : 48 : 57 64 discussion 64-5.
36. Barcellos LF, Sawcer S, Ramsay PP et al. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Hum Mol Genet 2006 : 15 : 2813 24.
37. Alizadeh M, Babron MC, Birebent B et al. Genetic interaction of CTLA-4 with HLA-DR15 in multiple sclerosis patients. Ann Neurol 2003 : 54 : 119 22.
38. Cairns LS, Phelps RG, Bowie L et al. The fine specificity and cytokine profile of T-helper cells responsive to the alpha3 chain of type IV collagen in Goodpasture's disease. J Am Soc Nephrol 2003 : 14 : 2801 12.
39. Roh EY, Park MH, Park H et al. Association of HLA-DR and -DQ genes with narcolepsy in Koreans: comparison with two control groups, randomly selected subjects and DRB1*1501-DQB1*0602-positive subjects. Hum Immunol 2006 : 67 : 749 55.
40. Hay CR, Ollier W, Pepper L et al. HLA class II profile: a weak determinant of factor VIII inhibitor development in severe haemophilia A. UKHCDO Inhibitor Working Party. Thromb Haemost 1997 : 77 : 234 7.
41. Phelps RG, Jones V, Turner AN, Rees AJ. Properties of HLA class II molecules divergently associated with Goodpasture's disease. Int Immunol 2000 : 12 : 1135 43.
42. Zsilak S, Gal J, Hodinka L et al. HLA-DR genotypes in familial rheumatoid arthritis: increased frequency of protective and neutral alleles in a multicase family. J Rheumatol 2005 : 32 : 2299 302.
43. Joko S, Numaga J, Maeda H. Immunogenetics of uveitis in leprosy. Jpn J Ophthalmol 1999 : 43 : 97 102.
44. Anderson GA, The surgical management of deformities of the hand in leprosy. J Bone Joint Surg Br 2006 : 88 : 290 4.
45. Stenzel A, Lu T, Koch WA et al. Patterns of linkage disequilibrium in the MHC region on human chromosome 6p. Hum Genet 2004 : 114 : 377 85.